The detail is in an old presentation, I posted on it a while back. The key point for investors is that the PFS accounts for the PSA. In other words, the reported financials in the PFS are net of the PSA among other costs. You can see how profitable we are net of PSA and imagine how profitable we would have been without the PSA. There was talk a while back of renegotiating more favourable terms for the PSA but John felt it would delay final approvals so they're working with what they've got at least until production starts up.
- Forums
- ASX - By Stock
- MYL
- When Does this bottom out
When Does this bottom out, page-8
Featured News
Add MYL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online